Dallah Healthcare Company (4004.SR)

SAR 157.6

(0.38%)

Market Cap (In SAR)

15.34 Billion

Revenue (In SAR)

2.94 Billion

Net Income (In SAR)

360.12 Million

Avg. Volume

67.81 Thousand

Currency
SAR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0-194.0
PE
-
EPS
-
Beta Value
0.214
ISIN
SA135G51UI10
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Dr. Ahmad Saleh Babaeer
Employee Count
-
Website
https://www.dallahhealth.com
Ipo Date
2012-12-17
Details
Dallah Healthcare Company provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical policlinics, compounds, and lands; and the provision of manpower and support services to hospitals and medical centers. It also manufactures and distributes pharmaceutical, herbal, and cosmetic products to retail pharmacies, health and beauty stores, hospitals, and governmental agencies. In addition, the company engages in the management and operation of hospitals owned by third parties; and the provision of other support services. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was founded in 1994 and is based in Riyadh, Saudi Arabia. Dallah Healthcare Company is the subsidiary of Dallah Al-Barakah Holding.

More Stocks